Takeda proposes sale of Shire drug to gain European approval [Reuters]
TAKEDA PHARMA (TKPYY)
NASDAQ:AMEX Investor Relations:
takeda.com/investors
Company Research
Source: Reuters
Takeda proposes sale of Shire drug to gain European approval | Reuters 1 Min Read (Reuters) - Takeda Pharmaceutical Co Ltd ( 4502.T ) has proposed to European regulators it could sell a Shire ( SHP.L ) treatment in development due to concerns of overlap in inflammatory bowel disease treatments and its own drug Entyvio as it seeks clearance for the two companies’ merger. The Japanese drug developer said it had proposed divesting Shire’s pipeline compound SHP647, which is currently in Phase III clinical trials, along with some associated rights. It said it did not expect the issue to delay its closing of the takeover of Shire and was the only issue it was discussing with European Union regulators after receiving approvals in China and Japan for the deal. Reporting by Arathy S Nair in Bengaluru All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2018 Reuters. All Rights Reserved. Takeda proposes sale of Shire drug to gain Europ
Show less
Read more
Impact Snapshot
Event Time:
TKPYY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TKPYY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TKPYY alerts
High impacting TAKEDA PHARMA news events
Weekly update
A roundup of the hottest topics